News | December 18, 2023
Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
10+ emerging markets, Japan & ANZ transition in final phase
10+ emerging markets, Japan & ANZ transition in final phase
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
European operations' revenue grew 58.4% to Rs 599.7 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Subscribe To Our Newsletter & Stay Updated
